{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:11:38Z","timestamp":1791285098335,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Innovation Project of Key Laboratory for Sports Medicine of Sichuan Province & General Administration of Sport","award":["SCZJJCC 02"],"award-info":[{"award-number":["SCZJJCC 02"]}]},{"name":"the Scientific and Technological Innovation Project of the General Administration of Sport of China","award":["22KJCX009"],"award-info":[{"award-number":["22KJCX009"]}]},{"name":"the Natural Science Foundation of Sichuan Province","award":["2022NSFSC1529"],"award-info":[{"award-number":["2022NSFSC1529"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11606-025-09950-4","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T16:43:29Z","timestamp":1763397809000},"page":"807-818","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effects of Glucagon-Like Peptide-1 Receptor Agonists After Treatment Withdrawal: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"41","author":[{"given":"Lei","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiming","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongsheng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiqun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benxiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranlin","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongfei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianmin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6171-4934","authenticated-orcid":false,"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"9950_CR1","doi-asserted-by":"crossref","unstructured":"Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19\u00b72 million participants. Lancet. 2016;387(10026):1377\u20131396.","DOI":"10.1016\/S0140-6736(16)30054-X"},{"issue":"10113","key":"9950_CR2","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1016\/S0140-6736(17)32129-3","volume":"390","author":"Worldwide trends in body-mass index","year":"2017","unstructured":"Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128\u00b79 million children, adolescents, and adults. Lancet. 2017;390(10113):2627-2642.","journal-title":"Lancet."},{"issue":"5","key":"9950_CR3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","volume":"15","author":"M Bl\u00fcher","year":"2019","unstructured":"Bl\u00fcher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15(5):288-298.","journal-title":"Nat Rev Endocrinol."},{"issue":"4","key":"9950_CR4","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jcpa.2017.03.007","volume":"156","author":"E Bomberg","year":"2017","unstructured":"Bomberg E, Birch L, Endenburg N, et al. The Financial Costs, Behaviour and Psychology of Obesity: A One Health Analysis. J Comp Pathol. 2017;156(4):310-325.","journal-title":"J Comp Pathol."},{"issue":"10031","key":"9950_CR5","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/S0140-6736(16)00271-3","volume":"387","author":"GA Bray","year":"2016","unstructured":"Bray GA, Fr\u00fchbeck G, Ryan DH, et al. Management of obesity. Lancet. 2016;387(10031):1947-1956.","journal-title":"Lancet."},{"key":"9950_CR6","doi-asserted-by":"publisher","first-page":"E21","DOI":"10.5888\/pcd21.230347","volume":"21","author":"W Rotunda","year":"2024","unstructured":"Rotunda W, Rains C, Jacobs SR, et al. Weight Loss in Short-Term Interventions for Physical Activity and Nutrition Among Adults With Overweight or Obesity: A Systematic Review and Meta-Analysis. Prev Chronic Dis. 2024;21:E21.","journal-title":"Prev Chronic Dis."},{"issue":"7","key":"9950_CR7","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1053\/j.gastro.2017.01.045","volume":"152","author":"VL Webb","year":"2017","unstructured":"Webb VL, Wadden TA. Intensive Lifestyle Intervention for Obesity: Principles,\u00a0Practices,\u00a0and Results. Gastroenterology. 2017;152(7):1752-1764.","journal-title":"Gastroenterology."},{"key":"9950_CR8","doi-asserted-by":"publisher","first-page":"101882","DOI":"10.1016\/j.eclinm.2023.101882","volume":"58","author":"M Chakhtoura","year":"2023","unstructured":"Chakhtoura M, Haber R, Ghezzawi M, et al. Pharmacotherapy of obesity: an update on the available medications and drugs under investigation. EClinicalMedicine. 2023;58:101882.","journal-title":"EClinicalMedicine."},{"issue":"4","key":"9950_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1177\/2042098613489721","volume":"4","author":"BM Cheung","year":"2013","unstructured":"Cheung BM, Cheung TT, Samaranayake NR. Safety of antiobesity drugs. Ther Adv Drug Saf. 2013;4(4):171-181.","journal-title":"Ther Adv Drug Saf."},{"issue":"1","key":"9950_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13098-023-01233-4","volume":"16","author":"W Coutinho","year":"2024","unstructured":"Coutinho W, Halpern B. Pharmacotherapy for obesity: moving towards efficacy improvement. Diabetol Metab Syndr. 2024;16(1):6.","journal-title":"Diabetol Metab Syndr."},{"issue":"7","key":"9950_CR11","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1210\/clinem\/dgab091","volume":"106","author":"K Kheniser","year":"2021","unstructured":"Kheniser K, Saxon DR, Kashyap SR. Long-Term Weight Loss Strategies for Obesity. J Clin Endocrinol Metab. 2021;106(7):1854-1866.","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"9950_CR12","doi-asserted-by":"publisher","first-page":"632","DOI":"10.4239\/wjd.v14.i6.632","volume":"14","author":"FS Liu","year":"2023","unstructured":"Liu FS, Wang S, Guo XS, et al. State of art on the mechanisms of laparoscopic sleeve gastrectomy in treating type 2 diabetes mellitus. World J Diabetes. 2023;14(6):632-655.","journal-title":"World J Diabetes."},{"key":"9950_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ajem.2024.10.050","volume":"87","author":"S Farooqi","year":"2025","unstructured":"Farooqi S, Montrief T, Koyfman A, et al. High risk and low incidence diseases: Bariatric surgery complications. Am J Emerg Med. 2025;87:113-122.","journal-title":"Am J Emerg Med."},{"issue":"11","key":"9950_CR14","doi-asserted-by":"publisher","first-page":"e029282","DOI":"10.1161\/JAHA.122.029282","volume":"12","author":"ED Michos","year":"2023","unstructured":"Michos ED, Lopez-Jimenez F, Gulati M. Role of Glucagon-Like Peptide-1 Receptor Agonists in Achieving Weight Loss and Improving Cardiovascular Outcomes in People With Overweight and Obesity. J Am Heart Assoc. 2023;12(11):e029282.","journal-title":"J Am Heart Assoc."},{"issue":"3","key":"9950_CR15","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1210\/jcem.87.3.8355","volume":"87","author":"MA Nauck","year":"2002","unstructured":"Nauck MA, Heimesaat MM, Behle K, et al. Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers. J Clin Endocrinol Metab. 2002;87(3):1239-1246.","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"9950_CR16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.eprac.2023.11.007","volume":"30","author":"HUH Ansari","year":"2024","unstructured":"Ansari HUH, Qazi SU, Sajid F, et al. Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight and Cardiometabolic Parameters in Individuals With Obesity and Without Diabetes: A Systematic Review and Meta-Analysis. Endocr Pract. 2024;30(2):160-171.","journal-title":"Endocr Pract."},{"issue":"3","key":"9950_CR17","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.ajcnut.2023.04.017","volume":"118","author":"Y Liu","year":"2023","unstructured":"Liu Y, Ruan B, Jiang H, et al. The Weight-loss Effect of GLP-1RAs Glucagon-Like Peptide-1 Receptor Agonists in Non-diabetic Individuals with Overweight or Obesity: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials. Am J Clin Nutr. 2023;118(3):614-626.","journal-title":"Am J Clin Nutr."},{"issue":"2","key":"9950_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2337\/ds20-0025","volume":"34","author":"W Polonsky","year":"2021","unstructured":"Polonsky W, Gamble C, Iyer N, et al. Exploring Why People With Type 2 Diabetes Do or Do Not Persist With Glucagon-Like Peptide-1 Receptor Agonist Therapy: A Qualitative Study. Diabetes Spectr. 2021;34(2):175-183.","journal-title":"Diabetes Spectr."},{"key":"9950_CR19","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.2147\/PPA.S277676","volume":"14","author":"T Weiss","year":"2020","unstructured":"Weiss T, Carr RD, Pal S, et al. Real-World Adherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United States. Patient Prefer Adherence. 2020;14:2337-2345.","journal-title":"Patient Prefer Adherence."},{"issue":"10","key":"9950_CR20","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1007\/s00125-023-05962-z","volume":"66","author":"T Karagiannis","year":"2023","unstructured":"Karagiannis T, Bekiari E, Tsapas A. Socioeconomic aspects of incretin-based therapy. Diabetologia. 2023;66(10):1859-1868.","journal-title":"Diabetologia."},{"key":"9950_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj. 2021;372:n71.","journal-title":"Bmj."},{"key":"9950_CR22","doi-asserted-by":"publisher","first-page":"102475","DOI":"10.1016\/j.eclinm.2024.102475","volume":"69","author":"SBK Jensen","year":"2024","unstructured":"Jensen SBK, Blond MB, Sandsdal RM, et al. Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial. EClinicalMedicine. 2024;69:102475.","journal-title":"EClinicalMedicine."},{"issue":"22","key":"9950_CR23","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1916038","volume":"382","author":"AS Kelly","year":"2020","unstructured":"Kelly AS, Auerbach P, Barrientos-Perez M, et al. A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity. N Engl J Med. 2020;382(22):2117-2128.","journal-title":"N Engl J Med."},{"issue":"5","key":"9950_CR24","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/liv.14065","volume":"39","author":"J Khoo","year":"2019","unstructured":"Khoo J, Hsiang JC, Taneja R, et al. Randomized trial comparing effects of weight loss by liraglutide with lifestyle modification in non-alcoholic fatty liver disease. Liver Int. 2019;39(5):941-949.","journal-title":"Liver Int."},{"issue":"1","key":"9950_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/acps.12982","volume":"139","author":"CK Svensson","year":"2019","unstructured":"Svensson CK, Larsen JR, Vedtofte L, et al. One-year follow-up on liraglutide treatment for prediabetes and overweight\/obesity in clozapine- or olanzapine-treated patients. Acta Psychiatr Scand. 2019;139(1):26-36.","journal-title":"Acta Psychiatr Scand."},{"issue":"8","key":"9950_CR26","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1111\/dom.14725","volume":"24","author":"JPH Wilding","year":"2022","unstructured":"Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553-1564.","journal-title":"Diabetes Obes Metab."},{"issue":"6","key":"9950_CR27","doi-asserted-by":"publisher","first-page":"e13435","DOI":"10.1111\/obr.13435","volume":"23","author":"J Iqbal","year":"2022","unstructured":"Iqbal J, Wu HX, Hu N, et al. Effect of glucagon-like peptide-1 receptor agonists on body weight in adults with obesity without diabetes mellitus-a systematic review and meta-analysis of randomized control trials. Obes Rev. 2022;23(6):e13435.","journal-title":"Obes Rev."},{"issue":"3","key":"9950_CR28","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/1753-0407.12198","volume":"7","author":"F Zhang","year":"2015","unstructured":"Zhang F, Tong Y, Su N, et al. Weight loss effect of glucagon-like peptide-1 mimetics on obese\/overweight adults without diabetes: A systematic review and meta-analysis of randomized controlled trials. J Diabetes. 2015;7(3):329-339.","journal-title":"J Diabetes."},{"issue":"1","key":"9950_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12933-022-01735-x","volume":"22","author":"RJ Massey","year":"2023","unstructured":"Massey RJ, Siddiqui MK, Pearson ER, et al. Weight variability and cardiovascular outcomes: a systematic review and meta-analysis. Cardiovasc Diabetol. 2023;22(1):5.","journal-title":"Cardiovasc Diabetol."},{"issue":"11","key":"9950_CR30","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1158\/1940-6207.CAPR-11-0133","volume":"4","author":"HJ Thompson","year":"2011","unstructured":"Thompson HJ, McTiernan A. Weight cycling and cancer: weighing the evidence of intermittent caloric restriction and cancer risk. Cancer Prev Res (Phila). 2011;4(11):1736-1742.","journal-title":"Cancer Prev Res (Phila)."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09950-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-025-09950-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09950-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T17:36:13Z","timestamp":1772645773000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-025-09950-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["9950"],"URL":"https:\/\/doi.org\/10.1007\/s11606-025-09950-4","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations:"}},{"value":"The authors declare that they do not have a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest:"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics and Consent to Participate:"}}]}}